Skip to main content

Awards

Three technologies developed at ICMAB, winning projects at the Santander X Award | Proyectos Emprendedores Universitarios 2026

UltraCell, LabsInLove, and LINCATH,  technologies developed at ICMAB-CSIC, have been selected as winning projects in the Santander X Award | University Entrepreneurial Projects 2026

As part of the collaboration agreement between the General CSIC Foundation (FGCSIC) and the Santander Foundation to promote research, entrepreneurship, and researcher training programs, these two institutions launched  the Santander X Award | University Entrepreneurial Projects 2026 awards.

The call, managed and coordinated by the FGCSIC for the awards allocated to the CSIC, aims to support the most promising university and CSIC entrepreneurial projects that are in the validation stage and preparing for market launch. The awardees in the first phase are, in the Category A, LINCATH and ULTRACELL. In the Category B, the ICMAB spinoff LabsInLove. The projects will now go on to compete at the national level. In the end, there will be only 10 winners.

ULTRACELL, hybrid supercapacitors that increase charge density without sacrificing power, thanks to an innovative laser treatment

UltraCell has been selected as a winning project in these awards. This technology is developing a new generation of high-energy-density carbon supercapacitors manufactured using laser technology, with the goal of delivering more sustainable, efficient, and scalable energy storage solutions.

Arevik Musheghyan, member of the LASER research group that developed the technology, said: "This recognition is an important milestone that will help us continue advancing the technology and accelerate its transfer to the market. We would like to thank the jury and the Santander X team for their confidence in our project, as well as the Fundación General CSIC for its support of scientific entrepreneurship and knowledge transfer. We also thank all the organizations (State Research Agency, Fundación General CSIC, XR4S, and the Government of Catalonia) and everyone who has contributed to the development of UltraCell. We remain committed to turning research into innovation with real-world impact."


Arevik Musheghyan with members of the LASER group at the ICMAB garden | ICMAB-CSIC

LabsinLove, a company focused on advancing a technology based on new boron compounds for neutron capture therapy (NCT) 

Another winner technology has been that of the spinoff LabsinLove, in which Rosario Nuñez takes part. Labsinlove, S.L. is a company dedicated to developing health technologies, which wants to enhance the last step in order to bring new anticancer drugs with a high boron content to actual human treatment. The company is participated by researchers from ICMAB-CSIC and Universidad de Granada. Boron Neutron Capture Therapy (BNCT) BNCT is a binary cancer therapy that combines an external neutron beam and a selective or targeted 10B-containing drug that preferentially concentrates in tumour tissues. The nuclear reaction between the neutron and the boron nucleus generates an alpha particle and a recoiling 7Li nucleus that creates a high degree of localized damage to the tumour cell without damaging healthy tissues.

LINCATH, lithium nanoencapsulation with the potential to improve the next generation of neutron capture therapy (NCT) for cancer treatment

Finally, LINCATH proposes a new approach to neutron capture therapy (NCT) based on the selective delivery of lithium, with the potential to improve the selectivity and effectiveness of current therapeutic strategies.

Esperanza Medina,  member of the SSC researhc group that developed the technology, said: "This is a highly disruptive technology, and this recognition highlights both its innovative potential and its prospects for technology transfer into future clinical applications. It is helping us raise the project's profile and accelerate its development. In addition, it gives us the opportunity to compete in the national Santander X Entrepreneurial Project Awards."

lincath_award.jpg
Esperanza Medina with members of the SSC group at the ICMAB garden | ICMAB-CSIC

Read more

Santander X Award | Proyectos Emprendedores 2026 - FGCSIC

ICMAB - The BRIGHT-GUIDE and ULTRACELL projects close the 2024 Indústria del Coneixement program with Investor Day

ICMAB - LabsinLove SL, the new ICMAB-CSIC spin off, will push Boron Neutron Cancer Therapy (BNCT) to the next step

Oriol
Oriol
22 July 2026